OBJECTIVES: Withania somnifera has been in use for several thousand years in Ayurveda to treat various neurological disorders. There is, however, not much scientific data on its protective role in neuronal pathology specifically against brain oxidative stress. Hence, an attempt is made in this work for systematic review and meta-analysis of W. somnifera on neurobehavioural disorders induced by brain oxidative stress in rodents. METHODS: A systematic search of the effect of W. somnifera on brain oxidative stress-induced neuronal pathology was performed using electronic databases. The systematic review was performed on neurobehavioural parameters, whereas meta-analysis of W. somnifera effect was done on oxidative stress markers (superoxide dismutase, catalase, glutathione peroxidase, glutathione and lipid peroxidation), nitrite, protein carbonyl, AchE, ChAT and Ach of rodent brain. Data were analysed using Review Manager Software. KEY FINDINGS: Twenty-eight studies were selected based upon the inclusion and exclusion criteria. W. somnifera appreciably inhibited the neurological abnormalities due to oxidative stress in rodent brain produced by different physical and chemical stimuli. W. somnifera also significantly restored the altered oxidative and other stress markers in different parts of rodent brain. SUMMARY: The systematic review provides scientific evidence for the traditional claim of W. somnifera use in different neurological aliments. However, future clinical trials are mandated to establish the therapeutic efficacy and safety in human beings.
OBJECTIVES:Withania somnifera has been in use for several thousand years in Ayurveda to treat various neurological disorders. There is, however, not much scientific data on its protective role in neuronal pathology specifically against brain oxidative stress. Hence, an attempt is made in this work for systematic review and meta-analysis of W. somnifera on neurobehavioural disorders induced by brain oxidative stress in rodents. METHODS: A systematic search of the effect of W. somnifera on brain oxidative stress-induced neuronal pathology was performed using electronic databases. The systematic review was performed on neurobehavioural parameters, whereas meta-analysis of W. somnifera effect was done on oxidative stress markers (superoxide dismutase, catalase, glutathione peroxidase, glutathione and lipid peroxidation), nitrite, protein carbonyl, AchE, ChAT and Ach of rodent brain. Data were analysed using Review Manager Software. KEY FINDINGS: Twenty-eight studies were selected based upon the inclusion and exclusion criteria. W. somnifera appreciably inhibited the neurological abnormalities due to oxidative stress in rodent brain produced by different physical and chemical stimuli. W. somnifera also significantly restored the altered oxidative and other stress markers in different parts of rodent brain. SUMMARY: The systematic review provides scientific evidence for the traditional claim of W. somnifera use in different neurological aliments. However, future clinical trials are mandated to establish the therapeutic efficacy and safety in human beings.
Authors: Sultan Alshehri; Fahad A Al-Abbasi; Mohammed M Ghoneim; Syed Sarim Imam; Muhammad Afzal; Khalid Saad Alharbi; Muhammad Shahid Nadeem; Nadeem Sayyed; Imran Kazmi Journal: Neurotox Res Date: 2022-01-04 Impact factor: 3.911
Authors: Grace Y Sun; Runting Li; Jiankun Cui; Mark Hannink; Zezong Gu; Kevin L Fritsche; Dennis B Lubahn; Agnes Simonyi Journal: Neuromolecular Med Date: 2016-05-21 Impact factor: 3.843
Authors: Kazim Sahin; Mehmet Tuzcu; Cemal Orhan; Hasan Gencoglu; Nurhan Sahin; Fatih Akdemir; Gaffari Turk; Ismet Yilmaz; Vijaya Juturu Journal: Evid Based Complement Alternat Med Date: 2018-04-29 Impact factor: 2.629
Authors: Jessica N Saykally; Haris Hatic; Kristen L Keeley; Subhash C Jain; Vijayalakshmi Ravindranath; Bruce A Citron Journal: Cell Transplant Date: 2017-07 Impact factor: 4.064
Authors: Kazim Sahin; Cemal Orhan; Fatih Akdemir; Mehmet Tuzcu; Hasan Gencoglu; Nurhan Sahin; Gaffari Turk; Ismet Yilmaz; Ibrahim H Ozercan; Vijaya Juturu Journal: BMC Complement Altern Med Date: 2016-08-26 Impact factor: 3.659